Forekomsten af bivirkninger, der kan indikere lægemiddelfrembragte muskelskader (forhøjet CPK, muskelsmerter, ledsmerter og smerter i benene) er klart højere ved cerivastatin 0, 8 mg sammenlignet med lavere doser eller andre statiner.
The incidence of adverse events which may indicate drug-induced muscle damage (CPK increased, myalgia, athralgia, and leg pain), is clearly higher on cerivastatin 0.8mg as compared with the lower dosages or other statins.